Treatment of Periodontal Intrabony Defects With A-PRF+ or EMD

Semmelweis University

Status: Completed

Conditions: Periodontal Diseases

Treatments: Procedure: A-PRF/EMD

Study type: Interventional

Funder types: Other

Identifiers

NCT04404374

SE TUKEB: 254/2017

Details and patient eligibility

About

The aim of this randomized clinical trial was to clinically evaluate and compare the healing of intrabony defects after treatment with advanced platelet-rich fibrin (A-PRF+) to enamel matrix derivatives (EMD) in periodontitis patients.

Full description

Thirty (30) intrabony defects of 18 patients (9 males, 9 females) were randomly divided in two treatment groups: test (n = 15) and control (n = 15). The intrabony defects were filled with A-PRF+ (n=15) in the test group, respectively with EMD in the control group, and fixed with sutures to ensure wound closure and stability.

Enrollment: 30 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• no systemic diseases that could influence the outcome of the therapy, a good level of oral hygiene, he presence of a 2-, 3-, or combined 2-3-wall intrabony defect with a defect angle of 20-40 (+/- 5) degrees, with a minimum PPD of 6 mm and intrabony component of a minimum 4 mm as detected on radiographs, no smoking

Exclusion criteria

• systemic diseases that could influence the outcome of the therapy, poor oral hygiene, smoking, horizontal bone loss

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

30 participants in 2 patient groups

A-PRF

Active Comparator group

Description:

Advanced Platelet-Rich Fibrin

Treatment:

Procedure: A-PRF/EMD

EMD

Active Comparator group

Description:

Enamel Matrix Derivatives

Treatment:

Procedure: A-PRF/EMD